MMP9 and neoplasm: IL-17 and transformed colonic epithelial cells promote tumor development by inhibiting immune effector cells and activating the STAT3 signaling pathway, as well as the secretion of pro-angiogenic mediators, matrix metalloproteinase 9 (MMP9), and VEGF (Thiele Orberg et al., 2017).